MCM2 and hepatocellular carcinoma: A relationship between FTX and miR-374a has been reported: FTX sponges miR-374a, resulting in the repression of Wnt/β-catenin signaling activity and consequent inhibition of hepatocellular carcinoma cell (HCC) epithelial–mesenchymal transition and invasion; moreover, FTX inhibits proliferation of HCC cells by binding the DNA replication licensing factor MCM2, and it is significantly downregulated in HCC tissues compared with normal liver tissues.